Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Jaguar Health (JAGX) Receivables - Net (2016 - 2025)

Jaguar Health (JAGX) has disclosed Receivables - Net for 11 consecutive years, with $1.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Receivables - Net rose 15.05% to $1.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.4 million, a 15.05% increase, with the full-year FY2024 number at $1.5 million, down 22.37% from a year prior.
  • Receivables - Net was $1.4 million for Q3 2025 at Jaguar Health, up from $1.2 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $5.9 million in Q1 2021 to a low of $987000.0 in Q1 2023.
  • A 5-year average of $1.9 million and a median of $1.5 million in 2022 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: surged 444.51% in 2021, then crashed 69.56% in 2022.
  • Jaguar Health's Receivables - Net stood at $1.7 million in 2021, then increased by 9.95% to $1.9 million in 2022, then grew by 4.68% to $2.0 million in 2023, then fell by 22.37% to $1.5 million in 2024, then dropped by 5.89% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Receivables - Net are $1.4 million (Q3 2025), $1.2 million (Q2 2025), and $1.2 million (Q1 2025).